Press Releases

Press Releases

Date Title Files

Jul 23, 2020

Dynavax and Medigen Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate

Jul 21, 2020

Dynavax Announces the Appointment of Two New Board Members

Jul 16, 2020

Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant

Jul 14, 2020

Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Medicago’s COVID-19 Vaccine Candidate with Dynavax’s CpG 1018 Adjuvant

Jul 08, 2020

Dynavax and Medicago Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate

Jun 22, 2020

Dynavax to Present at the H.C. Wainwright Virtual Fireside Chat Series

Jun 19, 2020

Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Clover Biopharmaceuticals’ COVID-19 S-Trimer Vaccine Candidate with CpG 1018 Adjuvant

Jun 09, 2020

Dynavax Completes Enrollment of Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodialysis

May 28, 2020

Dynavax to Present at the William Blair 40th Annual Growth Stock Conference

May 27, 2020

Dynavax Technologies Announces Closing of $80.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares